|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/11 ¤U¤È 02:12:56
|
´º³Í¤µ¦~À³¸Ó¬O¤£¿ùªº¤@¦~ ¥úñ¬ùª÷¥[¤W¨½µ{ª÷¡A¤µ¦~´NÁÈ¿ú¤F³á ªÑ¥»7.5»õ¥ª¥k¡A¬O¤p¦Ó¬üªº¥Í§Þ¤½¥q ³Ìªñ«nªº¶i«×·J¾ã¦p¤U 1. TJC0265¡A±ÂÅvª÷5150¸U¬üª÷¡Añ¬ùª÷À³¸Ó·|¶W¹L¤§«eJKB-122¡A2600¸U¬üª÷ªºÃ±¬ùª÷200¸U¬üª÷¡Añ¬ùª÷¤J±b®É¶¡¨Ì¾Ú·|pì«h»{¦C¡A³q±`ñ¬ù¤½§i«á3Ӥ뤺¤J±b 2. JKB-122¡A¨È¬w°Ï±ÂÅv¡AÀ³¸Ó¥i®³¨ì¨½µ{ª÷150¸U¬üª÷ 3. JKB-122 FDA¤G´Áµ²ªG¤Î¨ä¥L°Ï°ì±ÂÅv ´º³Í·sÃÄ 5¤d¸U¬ü¤¸±ÂÅvùÚÁl 04:102021/01/12 ¤u°Ó®É³ø §ù¿·»T¡þ¥x¥_³ø¾É ¡@´º³Í¥Í§Þ·sÃĶ}µo¦AÀò±¶³ø¡I11¤é«Å¥¬¡AºX¤U§Ü¨xÅÖºû¤Æ·sÃÄTJC0265¥H°ª¹F¬üª÷5,150¸Uªº¨½µ{¸O¥I´Ú¤ÎÂù¦ì¼Æ¾P°â¤À¼í¡A±ÂÅv¤j³°«íÁl¥Íª«ÂåÃÄ¡CùÚÁl±N¥þÅvt³d«áÄòTJC0265¦b¥þ²yªº«eÁ{§É¬ãµo¡BÁ{§É¶}µo©M¥«³õ°Ó·~¤Æ¡C ¡@³o¬O´º³ÍÄ~2019¦~6¤ë¡A±NªvÀø«D°sºë©Ê¯×ªÕ¨xª¢¡]NASH¡^·sÃÄJKB-122ªº¨È¬wÅv§Q¡A¥H2,600¸U¬üª÷©M¤W¥««áªº¾P°â¤À¼í±ÂÅvùÚÁl«á¡A¦A¶Ç¥X±ÂÅv§Q¦h¡A¤]¬O°ê¤º±©¤@¦³¨âÓ·sÃıÂÅvªº¤½¥q¡A«ü¼Ð·N¨ý¿@«p¡C ¡@´º³Í¸³¨Æªø¥Û^¯]ªí¥Ü¡A¦¹¦¸±ÂÅv®×ÃöÁä¦b©ó«íÁl¬Ý¨ì2020¦~¼w°êÀq§JÃļtªº¤Æ¦Xª«¥æ´«µû¦ôªº¸ê®Æµ²ªG«á¡A¥[³t»P´º³Íªº¦X§@¡A°ò©ó¹L¥h¦b¦X§@®×¤W²Ö¿nªº«H¥ô¡A³Ì«á§Ö³t«P¦¨TJC0265±ÂÅv¶}µo¡C ¡@¥Û^¯]«ü¥X¡ATJC0265¨t¦Cªº¤Æ¦Xª«¬°autotaxin§í¨î¾¯¡A¸Ó¼Ð¹v¾÷¨î¤w³Q¤åÄm³ø¾É¨ã¦³§ÜÅÖºû¤ÆªºÀø®Ä¡C¦¹¨t¦C¥ý¾ÉÃĪ«ªºÃĮĩó¬¡Åé°Êª«ªº¨xÅÖºû¤Æ»P«D°sºë©Ê¯×ªÕ¨xª¢¼Ò«¬Åã¥ÜÀø®Ä¡A»P°ê»ÚÃļt¦PÃþ¥ý¾ÉÃĪ«¬Û¤ñ¡AÀø®Ä²@¤£»¹¦â¡A¥Ø«e¥¿¶i¦æ²£«~Àu¤Æ¡A·Ç³Æ¬r²z¤Î¦w¥þ©ÊÃIJzªºµû¦ô¤¤¡C ¡@ªk¤Hªí¥Ü¡A¥HTJC0265©|¦b·Ç³Æ¶iÁ{§É«e¬r²zµû¦ô¡A§Y¯àÀò±o5,150¸U¬ü¤¸ªº±ÂÅvª÷©MÂù¦ì¼Æªº¾P°â¤À¼í¡A§Y¥iª¾¸ÓÃĪ«ªº¼ç¦b»ùÈ¡C¥t¥~¡A´º³Í¤wÀò¬ü°êFDA®Öã¤G´ÁÁ{§ÉªºJKB-122¡A¤]¹wp©ó¤@¤ë©³«e¦V¤¤°êCFDA´£¥X²Ä¤G´Á¤HÅéÁ{§É¸ÕÅç¼f¬d¡]IND¡^¥Ó½Ð°e¥ó¡A³Ì§Ö¥i¯à²Ä¤@©u©³¨ú±oIND®Öã¡A¦³¾÷·|´À¤½¥q±a¨Ó¤U¤@¶¥¬q¨½µ{ª÷¡A¬°2021¦~ªº·sÃĶ}µo²K¥[¦n±mÀY¡C ¡@¥Û^¯]ªí¥Ü¡A¬ü°ê¦³3,000¦h®a·sÃĬãµo¤½¥q¡A¥xÆW¦b¥Í§Þ·sÃħV¤O¤]¶W¹L30¦~¡A10¦h¦~«e¤~«_¥X·sªÞ¡A¥Ø«e¶È¦³10¦h®a·sÃÄì³Ð¬ãµo¤½¥q¡A¥B³W¼Ò³£¤£¤j¡A¦Ó¤¤°ê¦³´X¤Q®a¡A¦h¼Æ¥H¤¤ÃĬ°¥D¡A¥B¯×ªÕ¨xª¢¬ã¨s¦h¼ÆÁÙ¦b¤@´ÁÁ{§É¶¥¬q¤U¡A´º³Í§ë¤J¦¹»â°ì»á¨ã§Q°ò¡C ¡@ùÚÁl¬O¤¤°êª¾¦W¥Íª«»sÃĤ½¥q¡A±Mª`³Ð·sÃÄÁ{§É¶}µo¡A¦p¦ÛÅé§K¬Ì¡B®ø¤Æ¹D©M¤¤¼Ï¯«¸g¨t²Î¯e¯fªºªvÀøÃĪ«¡C¸Ó¤½¥q¥Ñ²`¦`±¾µPªºªC¦{®õ®æÂåÃĬì§Þ¡]300347.SZ¡^Âà§ë¸ê¡C |
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2023/2/10 ¤U¤È 01:37:08²Ä 32 ½g¦^À³
|
ÁÂÁ¦P¾Ç·|¨â¦ì«e½ú¤ôÆZ¤û¤j¡A¤Q¦~¤j... Åý¤j®a¬Ý¨ì³oÁû©ú¯] §Æ±æ¥i¥H¹³·íªì¥_·¥¬P¬P¤@¼Ë ±q10´X¤¸º¦¨ì¸Ó¦³ªº»ùÈ»ù¦ì---3¦ì¼Æ |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2023/2/2 ¤W¤È 10:31:25²Ä 31 ½g¦^À³
|
¥»¸ê®Æ¥Ñ¡@(¿³Âd¤½¥q)´º³Í¡@¤½¥q´£¨Ñ ¥Á°ê112¦~01¤ë ³æ¦ì¡G·s¥x¹ô¥a¤¸ ¶µ¥Ø Àç·~¦¬¤J²bÃB ¥»¤ë 22,742 ¥h¦~¦P´Á 0 ¼W´îª÷ÃB 22,742 ¼W´î¦Ê¤À¤ñ 999,999.99 ¥»¦~²Öp 22,742 ¥h¦~²Öp 0 ¼W´îª÷ÃB 22,742 ¼W´î¦Ê¤À¤ñ 999,999.99 ³Æµù / À禬ÅܤÆì¦]»¡©ú ¥»¦~«×À禬¬°¨ú±o±ÂÅv¨½µ{¸Oª÷USD75¸U |
|
|
·|û¡GDollars10152609 µoªí®É¶¡:2022/10/9 ¤W¤È 11:01:37²Ä 30 ½g¦^À³
|
¤£ª¾¥»¦¸JKB-122±ÂÅvñ¬ùª÷¹wp¦h¤[·|¤J±b¡H |
|
|
·|û¡G¶R³Ì§C½æ³Ì°ª10149057 µoªí®É¶¡:2022/10/1 ¤W¤È 10:50:37²Ä 29 ½g¦^À³
|
´º³Í¦AÀò±¶³ø ·sÃÄJKB-122¼Ú¬ü¥«³õ±ÂÅvIMUN 21:542022/09/29 ¤u°Ó §ù¿·»T ´º³Í¡]6549)¥Í§Þ·sÃĶ}µo¦AÀò±¶³ø¡I29¤é¤½§i¡AºX¤U·sÃÄJKB-122¼Ú¬ü¥«³õ±ÂÅvImmune Therapeutics,Inc¡]IMUN¡^¡AÁ`p³Ì°ª¨½µ{ª÷¬°5,725¸U¬ü¤¸¡BIMUN´¶³qªÑ600¸UªÑ¤Î¥~¥[µ¥È¬üª÷6,500¸U¤¸ªºªÑ²¼¡A¤W¥««á¨Ã¨É¦³2¢H¦Ü6¢Hªº¾P°â¤À¼í¡C ¦¹¥~¡AIMUN¨C¦~¥t»Ý¤ä¥I¬üª÷10¸U¤¸©T©wµLÀv±M§Qºû«ù¶Oµ¹´º³Í¡Aª½¨ì¸Ó¤½¥q¨ú±oÃÄÃÒ¤W¥«®Öã¡C ¸³¨Æªø¥Û^¯]ªí¥Ü¡AJKB-122¬O¦ÑÃÄ·s¥Î¡A¾AÀ³¯g¬°ªvÀø«D°sºë©Ê¯×ªÕ¨xª¢¡]NASH¡^¡A¸Ó·sÃĤw©ó2019¦~6¤ë¡A±N¨È¬wÅv§Q¥H2,600¸U¬üª÷©M¤W¥««áªº¾P°â¤À¼í±ÂÅvùÚÁl¡A¦¹¦¸«h¬O§â¨È¬w¥H¥~ªº²£«~¬ãµo¡BÁ{§É¸ÕÅç¡B»s³y¡B¾P°âÅv§Q±ÂÅv¤©IMUN¡C ´º³Í¬O¦b29¤éIMUNñq·sÃÄJKB-122¿W®a±ÂÅv¨È¬w¥H¥~ªº²£«~Á{§É¶}µo»P¸g¾P¦X¬ù¡C ¨Ì¨óij¡A´º³Í©óñ¬ù«á¦¬¨úñ¬ùª÷¤Î«áÄò¨Ì¨½µ{¸O¹F¦¨±¡§Î¦¬¨ú²£«~¶}µo©M§Þ³N²¾Â਽µ{ª÷¡B¾P°â¨½µ{ª÷µ¥¡A¦Xp³Ì°ª¥i¹F5,725¸U¬ü¤¸¡BIMUN´¶³qªÑ600¸UªÑ¤Î¥~¥[µ¥È¬üª÷6,500¸U¤¸ªºªÑ²¼¡C JKB-122¤W¥««á¡A´º³Í¤]¥i¦¬¨ú¾P°â¤À¦¨2¢H¦Ü6¢H¡AIMUNt¾á¸Ó¶µ¥Ø¦b¥þ²yªºÁ{§É«e¤ÎÁ{§É¬ã¨s¶O¥Î»PÃÄ«~µù¥U¬ÛÃö¶O¥Î¡A¨Ã©óÀò±o§åã¤W¥««á¡At³d¸Ó¶µ¥Ø¦b¥þ²yªº°Ó·~¤Æ±À¼s¾P°â¡C ¦X¬ù¦³®Ä´Á¶¡¤º¡AYµo¥Í³¡¤À©Î¥þ³¡¦A±ÂÅv¡A±N¨Ì²£«~¶}µo¶¥¬q¡AIMUNµ¹¥I´º³Í5¢H¡ã30¢Hªº¦A±ÂÅvª÷¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/12/9 ¤U¤È 02:22:07²Ä 28 ½g¦^À³
|
¬Ý¤½¥qºô¯¸¡A¥Ø«e³B©óÃÄ«~³Ì¾A¤Æ¤¤¡A¤§«e¬Ý³ø¾Éªº®ÄªGÀ³¸Ó«Ü¤£¿ù¡A§Æ±æ¤½¥q¥i¥H¥[§Ö³t«×¡Atiming©M¦X§@¹Ù¦ñ«Ü«n TJC0642 ¸Ó²£«~¬° COVID-19¯f¬r³J¥Õ¤À¸Ñ酶§í¨î¾¯¡A¬O¹ï¯f¬r¶i¤J±J¥D²ÓM«á¶i¦æ½Æ»sªº²Ä¤@¨BÆJªº¹K¤î§@¥Î¡A¤w¦³ªì¨Bªº¥ý¾É¤Æ¦Xª«¡A¥Ø«e¬ãµo¶¥¬q¥¿³B©ó¥ý¾É¤Æ¦Xª«³Ì¾A¤Æ¤¤¡A¶i¦æÃĪ«µ²ºcÀu¤Æ©M²ÓM¤º§Ü¯f¬r¬¡©Ê´ú¸Õ¡C www.chinatimes.com/realtimenews/20201013002424-260410 ´º³Í¥[¤J·s«aªvÀøÁɧ½ µo¥þ·s¤Æ¦Xª«·sÃÄ 11:302020/10/13 ¤u°Ó §ù¿·»T¡þ¥x¥_³ø¾É ´º³Í¡]6549¡^¥[¤J·s«aªvÀøÁɧ½¡I13¤é«Å¥¬¡A¦Û¥D¦X¦¨COVID-19¯f¬r ¡]SARS-CoV-2 «aª¬¯f¬r¡^³J¥Õ¤À¸Ñ酶§í¨î¾¯ ¡]protease inhibitor¡^¤p¤À¤l·sÃÄTJC-642¡A¸Ó¥þ·s¤Æ¦Xª«·sÃÄ¥iª½±µªý¤î¯f¬r½Æ»s¡A¥Ø«e¥¿³W¹º¥[³t¶i¦æ°Êª«¸ÕÅç¨Ã¶i¤J¤@´ÁÁ{§É¡C TJC-642³J¥Õ¤À¸Ñ酶§í¨î¬¡©Ê¡A¸g¶§©ú¤j¾ÇÅçÃÒ´ú¸Õµ²ªG¡A¦¨ªG¥¿±¡A¨ä§í¨î±j«×¬O¬¥¤Ç¨º³¡]Lopinavir¡^ªº¤@¤d¿¥H¤W¡C ´º³Í¤½§i«ü¥X¡A¸g¶§©ú¤j¾ÇÂå¾Ç¥Íª«§Þ³Nº[ÀËÅç¾Ç¨tº[¬ã¨s©ÒÅçÃÒ´ú¸Õ¡ATJC-642¥Î¥HªvÀø COVID-19¯f¬r¤Þ°_ªº¬ÛÃö¯e¯f¡Aµû¦ôµ²ªG¥¿±¡C |
|
|
·|û¡GLKK10022593 µoªí®É¶¡:2021/11/29 ¤U¤È 10:03:18²Ä 27 ½g¦^À³
|
½Ð°Ý¦³¤Hª¾¹D³o®a¤½¥qªºªñªp¶Ü? §Ú¬Ý5¤ë¤¤¨ì²{¦b³£¨S¦³¤H¦^ÂÐ, ¬O¦b¬ãµo¤¤¶Ü? |
|
|
·|û¡G¶R³Ì§C½æ³Ì°ª10149057 µoªí®É¶¡:2021/5/16 ¤U¤È 07:36:13²Ä 26 ½g¦^À³
|
½Ð°Ýþ¦ì¤j¤j¤F¸Ñ´º³Í ·s«aÃÄTJC-642 ¶i«×?? [¦³¹Ú³Ì¬ü§Æ±æ¬ÛÀH] ´º³Í¥[¤J·s«aªvÀøÁɧ½¡I13¤é«Å¥¬¦Û¥D¦X¦¨COVID-19¯f¬r¡]SARS- CoV-2 «aª¬¯f¬r¡^³J¥Õ¤À¸Ñ¡]¡]¡]¨»¨C¡^¡^¡^§í¨î¾¯¡]protease in hibitor¡^¤p¤À¤l·sÃÄTJC-642¡A¸Ó¥þ·s¤Æ¦Xª«·sÃÄ¥iª½±µªý¤î¯f¬r½Æ »s¡A¥Ø«e¥¿³W¹º¥[³t¶i¦æ°Êª«¸ÕÅç¨Ã¶i¤J¤@´ÁÁ{§É¡C ¡@¡@´º³Í¤½§i«ü¥X¡A¸g¶§©ú¤j¾ÇÂå¾Ç¥Íª«§Þ³Nº[ÀËÅç¾Ç¨tº[¬ã¨s©ÒÅçÃÒ ´ú¸Õ¡ATJC-642¥Î¥HªvÀø COVID-19¯f¬r¤Þ°_ªº¬ÛÃö¯e¯f¡Aµû¦ôµ²ªG¥¿ ±¡C ¡@¡@¸Óµû¦ô«ü¼Ð«ü¥XSARS-CoV-2«aª¬¯f¬r¶i¤J±J¥D²ÓM«á¡A±N«H¨Ï®ÖÁÞ ®Ö»Ä¡]mRNA¡^ÂàĶ¦¨pp1a¡Bpp1b¦h³J¥Õ¡A¶}©l¶i¦æ½Æ»sªº²Ä¤@¨B¬O§Q ¥Î³J¥Õ¤À¸Ñ¡]¡]¨»¨C¡^¡^¡A±N¦h³J¥Õ¤À¸Ñ¦¨½Æ»s©Ò»Ýªº¦UºØ¤£¦P¥\¯à ³J¥Õ¡A©Ò¥H³J¥Õ¤À¸Ñ¡]¨»¨C¡^¬¡©Ê¹ï¯f¬r½Æ»s¦ÜÃö«n¡A¦]¦¹¦¨¬°ÃÄ ª«¶}µo«n¼Ð¹v¡C ¡@¡@¸ÕÅçµ²ªGÅã¥Ü¡ATJC-642 ¹ïSARS-CoV-2 «aª¬¯f¬r³J¥Õ¤À¸Ñ¡]¡]¨»¨C¡^¡^§í¨î±j«×¡A¬O¬¥¤Ç¨º³¡]Lopinavir¡^ªº¤@¤d¿¥H¤W¡C´º³Í¤w ³W¹º¶i¦æ¯f¬r¶q°§C¸ÕÅç¡B°Êª«ÃĮĸÕÅç¡B°Êª«GLP¬r©Ê¸ÕÅç¤Î·sÃÄ Á{§É¤@´Á IND¥Ó½Ð¼f®Ö¡C<ºK¿ý¤u°Ó> |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/4/13 ¤W¤È 09:02:50²Ä 25 ½g¦^À³
|
¥»¸ê®Æ¥Ñ¡@(¿³Âd¤½¥q) ´º³Í¡@¤½¥q´£¨Ñ ¥Á°ê110¦~03¤ë ³æ¦ì¡G·s¥x¹ô¥a¤¸ ¶µ¥Ø Àç·~¦¬¤J²bÃB ¥»¤ë 21,056 ¥h¦~¦P´Á 0 ¼W´îª÷ÃB 21,056 ¼W´î¦Ê¤À¤ñ 999,999.99 ¥»¦~²Öp 21,056 ¥h¦~²Öp 0 ¼W´îª÷ÃB 21,056 ¼W´î¦Ê¤À¤ñ 999,999.99 ³Æµù/À禬ÅܤÆì¦]»¡©ú ¥»¦~«×À禬¬°¨ú±o±ÂÅvª÷USD75¸U |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/16 ¤U¤È 01:33:45²Ä 24 ½g¦^À³
|
´º³Í3/12¤½§i ¦¬¨ìTJ265·sÃÄñ¬ùª÷75¸U¬üª÷¤§«á ±µ¤U¨Ó¥DnnÃöª`ªº¬O ¤@¤ë©³«e¦V¤¤°êCFDA ´£¥XJKB122¤G´Á¤HÅéÁ{§É¸ÕÅç¼f¬d¡]IND¡^¥Ó½Ð ®Öã«á¡A¥i¦³¨½µ{ª÷150¸U¬üª÷¦¬¤J TJC265©MJKB122 Á`±ÂÅvª÷7750¸U¬üª÷¡AEPS°^Äm¬ù28¤¸ www.chinatimes.com/newspapers/20210112000171-260204 |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/16 ¤W¤È 10:30:46²Ä 23 ½g¦^À³
|
¹ï©ó¸ê¥»ÃB¤pªº·sÃĤ½¥q ¦pªG±z¬O¤½¥qªº¸gÀçªÌ ±z·|«ç»ò°µ©O¡H ´º³Í/¦w¦¨/¦]µØ¡K ³£«Üª`«¸êª÷¹B¥Î®Ä²v ¦]¬°·sÃıq¬ãµo¨ì®³¨ìÃÄÃÒ ¬Æ¦Ü¨ì³Ì«á¾P°â¨ì°^ÄmÀ禬 nªá¶O«Ü¤jªº¶O¥Î¡A®É¶¡¤]«Üªø «Ü©Èªº¬O Ãīܦn¡A¦ý¬O¿ú¤£°÷¥Î©Î¥Î§¹¤F ©Ò¥H¥L̶°¤¤¸ê·½¦b·sÃĬãµo©M¤p³W¼Ò¸ÕÅç ¤§«á´N¶}©l§ä±ÂÅv ¤@¤è±±ÂÅv¤§«á ¤½¥qªº¯à¤O©MÃÄ¥i¨£«×ÅÜ°ª ¤@¤è±«áÄò¤ñ¸û¤jªºÁ{§É¹êÅç¶O¥Î ¥i¥Ñ¦X§@¹Ù¦ñ¤ä¥X ¦Û¤v¦A§ë¤J¬ãµo·sÃÄ¡AÄ~Äò©¹«e¨« ³o´X®a§Úı±o¬O¬Û¹ï𷪺¤½¥q ¥L̪º°µªk§Ú¬O»{¦Pªº ÃĤ]³£¦³³°Äò±ÂÅv¥X¥h ¤p§Ì¤£¬OÂåÃÄ¥»¬ì ³oª©¥Øªº¦b´£¨Ñ¸ê°T¥¥x ¦pªG¦³¥ô¦ó«ü¥¿ ³£«D±`Åwªï¡A«D±`·PÁÂ🙏 |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/15 ¤U¤È 08:52:02²Ä 22 ½g¦^À³
|
J¤j¡A §Ú¦P·N³o¦¸¬O§Úªº²¨©¿ ÁÂÁ±zªº´£¿ô ¤U¦¸¤À¨É°T®§¡A§Ú·|§ó¤p¤ßª`·N ¤µ¤Ñ¤]¸òµo¨¥¤H²á«Ü¦h ¬Ýªk¤]³\¸ò±z¨Ç·L¤£¦P ´N¤@¨B¤@¸}¦L À˵ø¤½¥q¬O§_°µ¨ì¥LÌ©Ó¿Õªº §ÚÁÙ¬O¼ÖÆ[¬Ý«Ý´º³Íªº¥¼¨Ó¡A¦A¦¸·PÁ±z |
|
|
·|û¡GJimimycin10138346 µoªí®É¶¡:2021/3/15 ¤U¤È 08:35:47²Ä 21 ½g¦^À³
|
To:º¦ªù¤H¤j ¨ä¹ê§Ú¥h¦~´N°Ý¹L¡Aª¾¹D±z±o¨ìªºµªÂФF¡A§Ú·|©ß¥X°ÝÃD¥u¬O·Q´£¿ô±z§ë¸ên½T¹êªº§ä¸ê®Æ¡A¤×¨än¤À¨Éµ¹§O¤H¡C¦pªG§Ú¨S°Ý±z¡A±z¸ò¬Û«H±zªº¤HÁÙ·|«ùÄò´Á«Ý¤µ¦~ÁÙ¦³JKB-122 FDAªº¤G´Áµ²ªG§a¡]¨Æ¹ê¬O®Ú¥»ÁÙ¨S¦¬®×¡^¡A°h¤@¨BÁ¿´Nºâ·s»D¨º®ÉÔ´N¦³¶}©l¦¬¡AY¥J²Ó¬Ý¹êÅç³]p³£ª¾¹D¦¬¤T¦ì¼Æªº¯f¤HÁÙnµ¹ÃÄ´Á¶¡¡A¦¬¶°¼Æ¾Ú¡A¤ÀªR³ø§i¬O¤£¥i¯à¤@¦~µ²§ôªº¡C ¥t¥~±z¤À¨Éı±o¼ÖÆ[ªº·s»D»P¦~³ø¨ä¹ê¦³¨Ç¦b§Ú²´¤¤¬OÄY«ªºÄµÄÁ¡A§Ú¤]¸ò¤½¥q½T»{¹L«Ü¦h¨Æ¡A³£¬O·s»Dªí±¬Ý¤£¨ìªº¡C·íµM¼ÖÆ[¤]¬O¦n¨Æ¡A¬Ýªk³£´L«¦ý¦Ü¤Ö´£¨Ñ¤½¥qªº°T®§n·Ç½T¡Aµ¹±zªº«Øij¡C PS.§Ú¬O¦´ÁªÑªF |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/15 ¤U¤È 07:14:48²Ä 20 ½g¦^À³
|
èè¶K¿ùª©¡A«·s¶K¤@¤U Jimimycin¤j¡A ¤µ¤Ñ°Ý¤½¥q FDA¤G´Á½T¹êÁÙ¨S¶}©l¦¬®× ¥Dn¬OFDA¸ÕÅç¶O¥Î¤ä¥X¤£¤Ö ¤½¥q¥Ø«eJKB122Á{§É¹êÅ給²¤ ¥H¦X§@¹Ù¦ñùÚÁl¬°¥D ¤w¸g¦V¤¤°êCFDA´£¥X²Ä¤G´Á¤HÅéÁ{§É¸ÕÅç¼f¬d¡]IND¡^¥Ó½Ð°e¥ó Y¨ú±oIND®Öã ¦³¾÷·|´À¤½¥q±a¨Ó¤U¤@¶¥¬q¨½µ{ª÷ |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/14 ¤U¤È 12:17:01²Ä 19 ½g¦^À³
|
¤Ñ¦æ¤j §ë¸ê¤H¬Ý¨ì´º³Íªº»ùÈ ¦ÛµM´N·|¤Wº¦¡A¤@°_´Á«Ý¤§ |
|
|
·|û¡G¤Ñ¦æ10138985 µoªí®É¶¡:2021/3/13 ¤U¤È 05:22:46²Ä 18 ½g¦^À³
|
º¦ªù¤H¤j:§Æ±æ¤U¬P´ÁªÑ»ù·|¦³¤ÏÀ³ |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/13 ¤U¤È 03:56:10²Ä 17 ½g¦^À³
|
ÁÂÁ¤Ѧæ¤j°T®§ ±q¦~³ø´¦ÅS°T®§¡Aı±o´º³ÍªºÃĹê¤O¤£¿ù JKB-122¹ï«D°s精©Ê¯×ªÕ¨x(NAFLD)©M¦ÛÅé§K¬Ì©Ê¨xª¢(AIH)¤§¥Dn«ü¼Ð¹F¨ì²Îp¤WÅãµÛ®ÄªG ¥[¤W¸òÀq§J¦X§@¡A²{¦b¤S«Ü§C»ù¡AÓ¤H¬O¼ÖÆ[¬Ý«Ý¥L¥¼¨Óªº¼ç¤O ¦~³ø¤º®e¡G 108 年度Àç·~p¹º¹ê¬I¦¨ªG ¥»¤½¥qÄ~ 107 年©ó JKB-122 ¤p¤À¤l·sÃĪv療«D°s精©Ê¯×ªÕ¨x(NAFLD)¤§¥Dn«ü¼Ð ¹F¨ì²Îp¤WÅãµÛ®ÄªG«á¡A108 年度 JKB-122 ¤p¤À¤l·sÃĪv療¦ÛÅé§K¬Ì©Ê¨xª¢(AIH)¤§²Ä ¤G´Á臨§É¸ÕÅç¸Ñª¼µ²ªG¡A©ó¥Dn«ü¼Ð¹F¨ì²Îp¤WÅãµÛ®ÄªG¡A¦b·sÃĤG´Á¤HÅé臨§É¸ÕÅç ¤S¨ú±o¥t¤@¬ð¯}©Êªº¶i®i¡C¦b±M利§G§½¤W¥ç¦³¬Û·íªº«¤jµo®i¡F¨ä¤¤¥»¤½¥q¦ÛÅé§K¬Ì ©Ê¨xª¢(AIH)臨§É¸ÕÅ礤²£«~¡A¥Ó½Ð¤§±M利¦WºÙ¡uToll-Like Receptor 4 Antagonists and Use in Autoimmune Liver Diseases¡v¡A¤À§OÀò±o¿D¤j利¨È¡B«X羅´µ¤ÎÁú°ê¤§±M利ÃÒ®Ñ |
|
|
·|û¡G¤Ñ¦æ10138985 µoªí®É¶¡:2021/3/13 ¤U¤È 03:30:07²Ä 16 ½g¦^À³
|
´º³Í:¤½§i¥»¤½¥q¦¬¨ì±ÂÅvùÚÁl¥Íª«ÂåÃĬì§Þ·sÃÄTJC-265¤§Ã±¬ùª÷ ¹d¦ëºô·s»D¤¤¤ß¡°¨Ó·½¡G¥xÆWÃÒ¨é¥æ©ö©Ò2021/03/12 15:40 ²Ä44´Ú 1.¨Æ¹êµo¥Í¤é:110/03/12 2.¤½¥q¦WºÙ:´º³Í¥Íª«¬ì§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¤@¡B¥»¤½¥q©ó2021¦~1¤ë11¤é»PùÚÁl¥Íª«Ã±¸p¤§·sÃÄTJC-265·sÃÄ¿W®a±ÂÅv¦X¬ù¡C ¤G¡BùÚÁl¥Íª«¨Ì¾Ú¦X¬ù©ó¤µ¤é¤ä¥I¥»¤½¥qñ¬ùª÷75¸U¬üª÷¡C ¤T¡B¤U¤@¶¥¬q¨½µ{ª÷±N¨Ì¦X¬ù¬ù©w¤ä¥I¡A©ó¦¬¨ì´Ú¶µ®É¦A¦æ¤½§i¡C 6.¦]À³±¹¬I:µL¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/12 ¤U¤È 06:22:43²Ä 15 ½g¦^À³
|
ÁÂÁÂJ¤j´£¿ô§ó¥¿ ¤U¶g¦A¸ò¤½¥q½T»{¸Ô²Ó±¡§Î |
|
|
·|û¡GJimimycin10138346 µoªí®É¶¡:2021/3/12 ¤U¤È 05:38:13²Ä 14 ½g¦^À³
|
To:º¦ªù¤H¤j ¦pªG±z¬O«ü¨ºÓ·s»Dªº¸Ü¡AÀ³¸Ó¬O¤U±³o®×§a~ ClinicalTrials.gov Identifier: NCT04371718 Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH) Recruitment Status: Not yet recruiting ¥u¬OÀò·Ç°õ¦æ¦Ó¤w¡A¹ê»Ú¤Wªºª¬ºA¬O¡§®Ú¥»ÁÙ¨S¦³¶}©l©Û¶Ò¡¨ò¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/12 ¤U¤È 05:22:58²Ä 13 ½g¦^À³
|
J¤j¡A¬O«ü¥H¤U³oÓ³á¡A¥Ø«e¦¬®×¤¤ ´º³Í§Ü¨xª¢·sÃÄ ¬üFDAÀòã°õ¦æ¤G´Á¤HÅéÁ{§É¸ÕÅç 2020-11-07 13:52 ¸gÀÙ¤é³ø °OªÌÁ¬f§»¡þ§Y®É³ø¾É ´º³Í¥Í§Þ¡]6549¡^¤µ¡]7¡^¤é¤½§i¡A¤½¥q¬ãµo¤¤·sÃÄJKB-122¡A¾A¥Î¦b¦ÛÅé§K¬Ì©Ê¨xª¢¡]AIH¡^¡A³q¹L¬ü°ê¹«~ÃĪ«ºÞ²z§½¡]FDA¡^®Öã°õ¦æ²Ä¤G´Á ¤HÅéÁ{§É¸ÕÅç¡C ´º³Íªí¥Ü¡A³o¶µ¦W¬°JKB-122ªº·sÃÄ¡A¬OÂǥѫú§ÜToll-Like Receptor 4¡]TLR4¡^¤§§@¥Î¡AªvÀø¦ÛÅé§K¬Ì©Ê¨xª¢¡C²{¥¿¹wp¶i¦æ²Ä¤G´ÁÁ{§É¸ÕÅç¡A¨Ã¦P®É°Ó½Í°ê»Ú±ÂÅv¡C ¨Ì¾ÚTechNavio¤Î¤u¬ã°|¹w¦ô¡AAIHªº¥«³õ2015¦~¬ù¦b2.51»õ¬ü¤¸¡A¹w¦ô2022¦~±N¥i¹F7»õ¬ü¤¸¡C¦~½Æ¦X¦¨ªø²v¬°22.7%¡C¥Ø«eAIH¨ÃµL®Ö㪺ªvÀøÃĪ«¡A²{¦æÀøªk¥Dn¨Ï¥ÎÃþ©T¾J¤Î§K¬Ì§í¨î¾¯¨Ó±±¨î¯f±¡¡A±©µLªk®Úªv¡F±wªÌ¥²¶·ªø´ÁªA¥ÎÃĪ«¡A¨Ãl¥Í¥X¸û¦hÄY«°Æ§@¥Î¡C |
|
|
·|û¡GJimimycin10138346 µoªí®É¶¡:2021/3/12 ¤U¤È 05:03:00²Ä 12 ½g¦^À³
|
º¥ý®¥³ß´º³Í®³¨ìñ¬ùª÷ To:´xªù¤H¤j ½Ð°Ý±z»¡ªº¡G¤µ¦~ÁÙ¦³JKB-122 FDA¤G´Áµ²ªG ¬O«üþÓµoFDAªº®×¤l©O¡H²{¦b¤w¸g¤T¤ë¤F¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/12 ¤U¤È 03:32:35²Ä 11 ½g¦^À³
|
TJ265¦¬¨ìñ¬ùª÷¤F ¦ý¬O¤ñ¹w¦ôªº¤Ö¡A¥u¦³75¸U¬üª÷ À³¸Ó¬O¦]¬°³oÃÄÁÙ¦b¤ñ¸û¦´Á¶¥¬q ©Ò¥H¤½¥qn¥[³tÁ{§É¹êÅç ¤~¯à®³¨ì¦U¶¥¬qªº¨½µ{ª÷ ¡]TJC265©MJKB122 Á`±ÂÅvª÷7750¸U¬üª÷¡AEPS°^Äm28¤¸¡^ ¦pªG¥[¤WJKB122¨½µ{ª÷150¸U¡A¦@225¸U¬üª÷ EPS¬ù°^Äm0.84¤¸ ¤µ¦~ÁÙ¦³JKB-122 FDA¤G´Áµ²ªG ªÑ»ù³B©ó§CÀÉ¡A·ÀI¦³¡AÃzµo¤OµL😂 ¥»¸ê®Æ¥Ñ¡@(¿³Âd¤½¥q) 6549 ´º³Í ¡@¤½¥q´£¨Ñ §Ç¸¹ 1 µo¨¥¤é´Á 110/03/12 µo¨¥®É¶¡ 15:17:55 µo¨¥¤H °KÂE©÷ µo¨¥¤H¾ºÙ Á`¸g²z µo¨¥¤H¹q¸Ü 03-6587721 ¥D¦® ¤½§i¥»¤½¥q¦¬¨ì±ÂÅvùÚÁl¥Íª«ÂåÃĬì§Þ·sÃÄTJC-265¤§Ã±¬ùª÷ ²Å¦X±ø´Ú ¡@²Ä 44 ´Ú ¨Æ¹êµo¥Í¤é 110/03/12 »¡©ú 1.¨Æ¹êµo¥Í¤é:110/03/12 2.¤½¥q¦WºÙ:´º³Í¥Íª«¬ì§ÞªÑ¥÷¦³¤½¥q 3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©Î¤l¤½¥q):¥»¤½¥q 4.¬Û¤¬«ùªÑ¤ñ¨Ò:¤£¾A¥Î 5.µo¥Í½t¥Ñ: ¤@¡B¥»¤½¥q©ó2021¦~1¤ë11¤é»PùÚÁl¥Íª«Ã±¸p¤§·sÃÄTJC-265·sÃÄ¿W®a±ÂÅv¦X¬ù¡C ¤G¡BùÚÁl¥Íª«¨Ì¾Ú¦X¬ù©ó¤µ¤é¤ä¥I¥»¤½¥qñ¬ùª÷75¸U¬üª÷¡C ¤T¡B¤U¤@¶¥¬q¨½µ{ª÷±N¨Ì¦X¬ù¬ù©w¤ä¥I¡A©ó¦¬¨ì´Ú¶µ®É¦A¦æ¤½§i¡C 6.¦]À³±¹¬I:µL¡C 7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:µL¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/12 ¤U¤È 01:16:00²Ä 10 ½g¦^À³
|
¦pªGñ¬ùª÷¦Ü¤Ö200¸U¬üª÷¡A¥[¤W¨½µ{ª÷150¸U¬üª÷¡A¥HªÑ¥»7.5»õpºâ¡Aeps°^Äm¬ù1.3¤¸ èè¸ß°Ý¤½¥q¡A¸ê°T·J¾ã¤À¨É¦p¤U 1. TJC0265¡A±ÂÅvª÷5150¸U¬üª÷¡Añ¬ùª÷³ÌºCQ2·|¤J±b¡Añ¬ùª÷¦h¤Ö¤£«K§iª¾¡]±À´ú·|¤ñ¤§«e2600¸U¬üª÷ªº200¸Uñ¬ùª÷°ª¡^ 2. JKB-122¡A¸ê®Æ¤w¸g°e¥X¡Aµ¥«Ý®Öã¡A®Öã«á¨Ì¾Ú¦X¬ù¥i®³¨ì¨½µ{ª÷150¸U¬üª÷ 3. TJC-642·s«a¬Ì±¡ªvÀø¥ÎÃĮĪG¤£¿ù¡A¥Ø«e°µ³Ì«á°t¤è½Õ¾ã½T»{¡A¦]¬°¥Ø¼Ð¬O¥þ¥@¬É¨Ï¥Î¡A»P¬ü°êµ¥¦X§@¹Ù¦ñ¡A°Q½×¦p¦ó¥[³t¶i¦æ¸ÕÅç ´º³Í¥[¤J·s«aªvÀøÁɧ½ µo¥þ·s¤Æ¦Xª«·sÃÄ 11:302020/10/13 ¤u°Ó §ù¿·»T¡þ¥x¥_³ø¾É ´º³Í¡]6549¡^¥[¤J·s«aªvÀøÁɧ½¡I13¤é«Å¥¬¡A¦Û¥D¦X¦¨COVID-19¯f¬r ¡]SARS-CoV-2 «aª¬¯f¬r¡^³J¥Õ¤À¸Ñ酶§í¨î¾¯ ¡]protease inhibitor¡^¤p¤À¤l·sÃÄTJC-642¡A¸Ó¥þ·s¤Æ¦Xª«·sÃÄ¥iª½±µªý¤î¯f¬r½Æ»s¡A¥Ø«e¥¿³W¹º¥[³t¶i¦æ°Êª«¸ÕÅç¨Ã¶i¤J¤@´ÁÁ{§É¡C TJC-642³J¥Õ¤À¸Ñ酶§í¨î¬¡©Ê¡A¸g¶§©ú¤j¾ÇÅçÃÒ´ú¸Õµ²ªG¡A¦¨ªG¥¿±¡A¨ä§í¨î±j«×¬O¬¥¤Ç¨º³¡]Lopinavir¡^ªº¤@¤d¿¥H¤W¡C ´º³Í¤½§i«ü¥X¡A¸g¶§©ú¤j¾ÇÂå¾Ç¥Íª«§Þ³Nº[ÀËÅç¾Ç¨tº[¬ã¨s©ÒÅçÃÒ´ú¸Õ¡ATJC-642¥Î¥HªvÀø COVID-19¯f¬r¤Þ°_ªº¬ÛÃö¯e¯f¡Aµû¦ôµ²ªG¥¿±¡C ¸Óµû¦ô«ü¼Ð«ü¥X¡ASARS-CoV-2«aª¬¯f¬r¶i¤J±J¥D²ÓM«á¡A±N«H¨Ï®ÖÁޮֻġ]mRNA¡^ÂàĶ¦¨pp1a, pp1b¦h³J¥Õ¡A¶}©l¶i¦æ½Æ»sªº²Ä¤@¨B¬O§Q¥Î³J¥Õ¤À¸Ñ酶¡A±N¦h³J¥Õ¤À¸Ñ¦¨½Æ»s©Ò»Ýªº¦UºØ¤£¦P¥\¯à³J¥Õ¡A©Ò¥H³J¥Õ¤À¸Ñ酶¬¡©Ê¹ï¯f¬r½Æ»s¦ÜÃö«n¡A¦]¦¹¦¨¬°ÃĪ«¶}µo«n¼Ð¹v¡C ¸ÕÅçµ²ªGÅã¥Ü¡ATJC-642¹ïSARS-CoV-2«aª¬¯f¬r³J¥Õ¤À¸Ñ酶§í¨î±j«×¡A¬O¬¥¤Ç¨º³¡]Lopinavir¡^ ªº¤@¤d¿¥H¤W¡C ´º³Í¤w³W¹º¶i¦æ¯f¬r¶q°§C¸ÕÅç¡B°Êª«ÃĮĸÕÅç¡B°Êª«GLP¬r©Ê¸ÕÅç¤Î·sÃÄÁ{§É¤@´Á IND¥Ó½Ð¼f®Ö¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/12 ¤W¤È 09:33:13²Ä 9 ½g¦^À³
|
´º³ÍªºÃÄ¥HªvÀøºC©Ê¨x¯f¡B¦UºØ¾¹©xÅÖºû¤Æ¯e¯f¥H¤Î¹L±Ó/®ð³Ý¬°¥D¡C³o¨Ç¯e¯f¥]§t¨xµoª¢/¨xÅÖºû¤Æ¡A«D°sºë©Ê¯×ªÕ¨x¯f¡A«D°sºë©Ê¯×ªÕ¨xª¢¡A¦ÛÅé§K¬Ì©Ê¨xª¢¡A®ð³Ý¥H¤Î²§¦ì©Ê¥Ö½§ª¢µ¥µ¥¡C ¸Ô²ÓÁ{§É¶i«×¤½¥qºô¯¸¦³¤½§i ´£¿ôªº¬O¡A¤£¦Pªº¾AÀ³¯e¯f¡A¦b¤£¦P°ê®a¶i¦æ¤£¦P´Á§OªºÁ{§É¶i«×¡A¥]§t¨xµoª¢/¨xÅÖºû¤Æ¡A«D°sºë©Ê¯×ªÕ¨x¯f¡A«D°sºë©Ê¯×ªÕ¨xª¢¡A¦ÛÅé§K¬Ì©Ê¨xª¢¡A³o¨ÇÃĹï¨x¯fªºªvÀø¡A¥un¦³¤@Ó®³¨ìÃÄÃÒ¡A³£«Ü¤£¿ù www.taiwanj.com/mynews/mynews_company_tw/mynews_category1_id:4 ¤½¥qºô¯¸Â²¤¶JKB-122ªºª¬ªp¡A´£¨Ñ¦U¦ì¤j¤j°Ñ¦Ò JKB-122¬O¤@Ó¤p¤À¤lÃĪ«©MJKB-121¨ã¦³¬Û¦üªºµ²ºc¥H¤Î¬¡©Ê¡A ¨ä§@¥Î¾÷ÂରTLR4 (Toll-like receptor 4) ªºªø®Ä«ú§Ü¾¯¡CJKB-122¥ý¾ÉÃĪ«¥Ø«e¤w¨ú±o¥xÆWFDA¥H¤Î¬ü°êFDAªº®Ö¥i¡A¥¿¦b¥xÆW©Û¶Ò¯f¤H¶i¦æ²Ä¤G´ÁÁ{§É¸ÕÅç [identifier number, NCT02149368]¡A¾AÀ³¯g¬°C¨x¤Þ°_¤§ºC©Ê¨x¯f(CLD)¥H¤Î«D°sºë©Ê¯×ªÕ¨x¯f(NAFLD)¡C¬°¤F¼W±jJKB-122ªºÀø®Ä¡A´º³Í¥Í§Þ¤]¶i¦æ¦³ÃöÃĪ«ÄÀ©ñ¤Î¾¯¶q¤è±ªº¾¯«¬§ï¨}¨Ã¥Ó½Ð±M§Q«OÅ@¡C¥Ø«e¦bCLD¥H¤ÎNAFLDªºªvÀø¤W¤´¯Ê¤Ö¦w¥þ¦³®ÄªºÃĪ«¡A¦b¬ü°ê¤j¬ù¥|¦Ê¸UC«¬¨xª¢¯f±w»P¤@¦Ê¸UB«¬¨xª¢¯f±w»X¨ü¨Öµo¯g¤§W¡F¦Ó«D°sºë©Ê¯×ªÕ¨x¯f¦bªÎDªº±Ú¸s¤¤«D±`´¶¹M¡A¦b¤£¦P°Ï°ì¤¤¬ù¥e·í¦aÁ`¤H¤fªº9-37%¡C«D°sºë©Ê¯×ªÕ¨x¯fªº¯fµ{¬O¥Ñ©ó¯×ªÕ¦b¨xŦ°ï¿n (¯×ªÕ¨x)¦Óºt¶i¦¨«D°sºë©Ê¯×ªÕ¨xª¢¡A¦Ó¨xª¢ªº¯S¼x¬Oµoª¢¤ÏÀ³¥H¤Î¨xŦÅÖºû¤Æ¡AJKB-122§ÜÅÖºû¤Æ¡B½Õ¾ã§K¬Ì¥H¤Îªø´Á¦w¥þ©Êªº¯S©Ê¨ÓªvÀøCLD»PNAFLD¡A±N·|¬O¤@Ó¦³®Ä¤Î³Ð·sªº¤è¦V¡C JKB-122¦b¬¡Åé°Êª«¸ÕÅ礤ÃÒ¹ê¥i¥H§ïµ½¦ÛÅé§K¬Ì©Ê¨xª¢(AIH)¡A°§CALT¥H¤ÎAST¡A¤]§í¨î¨xŦ¤¤«P¶iµoª¢ªº¬ÛÃö¦]¤lIFN-£^, IL-1£], IL-5, IL-6¥H¤ÎTNF-£\¡CJKB-122¦b2015¦~ªìÀò±o¬ü°êFDAªº©t¨àÃÄ»{ÃÒ¡A¨Ã¨ú±oFDAªº³\¥i¥Ø«e¦b¬ü°ê¶i¦æ²Ä¤G´ÁªºÁ{§É¸ÕÅç¡C ¦b¬ü°êªº²Ä¤G´ÁÁ{§É¥ý¾É¸ÕÅ礤¤]µo²{JKB-122¹ïCrohn¡¦s disease¨ã¦³ÅãµÛªºÀø®Ä¡A¥Ø«e¥þ²y¿©±wµoª¢©Ê¸z¹D¯e¯fªº¯f¤H¶W¹L¤@¦Ê¸U¡A´º³Í¾Ö¦³JKB-122ªvÀøCrohn¡¦s diseaseªº±M§Q¡A¥B¥¿¦bµo®i³æ¿W¨Ï¥ÎJKB-122©Î¬O¥HJKB-122·f°t¥Ø«eªº¼Ð·ÇªvÀøÃĪ«ªºÀø®Ä¤Î¦w¥þ©Ê¶}µo¡C |
|
|
·|û¡GJimimycin10138346 µoªí®É¶¡:2021/3/12 ¤W¤È 08:42:08²Ä 8 ½g¦^À³
|
¤é ´Á¡G2021¦~01¤ë15¤é ¤½¥q¦WºÙ¡G´º³Í (6549) ¥D ¦®¡G´º³Í·sÃÄJKB-122¤w¥Ñ±ÂÅv¹ï¶HùÚÁl¥Íª«¦V¤¤°ê°ê®aÃÄ«~ºÊ·þºÞ²z§½¥Ó½Ð¤HÅé¤G´ÁÁ{§É¸ÕÅç¼f¬d(IND) ³oÀɳ̷sªº¤½§i¡AÃÄ«e°}¤l¤~è¥Ó½Ð¤G´Á¸ÕÅ窺¼f¬d¦Ó¤w¡A¥i¥H²z¸Ñ¤jº¦«Ü¿³¾Ä¡A¦ýÁÙ¨S¦³¶}©l°µ¤G´Á´N·QµÛ°Ý¤T´Áµ²§ô«á®³ÃÄÃÒµ¥¦h¤[ªº¨Æ¡A¯uªºÁÙ¤Ó¦°Ú... |
|
|
·|û¡Gymyu398810142972 µoªí®É¶¡:2021/3/11 ¤U¤È 11:52:31²Ä 7 ½g¦^À³
|
º¦ªù¤j¤j:½Ð°ÝY²Ä¤T´ÁÁ{§É¹êÅç³q¹L¼Ð·Ç«á,¨ì®³ÃÄÃÒ³q±`®É¶¡nµ¥¤@¦~¶Ü |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/11 ¤U¤È 05:07:32²Ä 6 ½g¦^À³
|
«¢Åo¤j¡A¶}¤ß¤S¨£±¤F ²¢²¢»ù¤S¦³¼ç¤Oªº¡A§Ú³Ì·R😀 ¥Í§ÞªÑ¯uªºn©ñ¤@¬q®É¶¡ ¨Óµ¥Á{§É¶}¼úµ²ªG©Î±ÂÅv ¨S¿ìªk¹³¹q¤lªÑ¨CӤ릳À禬 ¦ý¬O¤@¥¹®³¨ìÃÄÃÒ ¬YÓ»â°ì´N¬O§Aªº¤F ¥i¥H¦Y¦n´X¦~ |
|
|
·|û¡G«¢Åo¡ã¡ã¡ã¡ã10150018 µoªí®É¶¡:2021/3/11 ¤U¤È 04:18:25²Ä 5 ½g¦^À³
|
º¦ªù¤H¤j¡ã¤S¨£±¤F¡I«¢«¢¡I §Ú観¤J¤â´º³Í¤F¡I¨ä¹ê§Ú¹ï·sÃĨS¬ã¨s°Õ¡I¡ã ´N¤jP¬Ý¤@¤U¡I¤Ï¥¿²¢²¢»ù¡A´NÁʤJ µ¥¤]¤£¿ù¡I´N¸òµÛ¦³¸gÅ窺¤H¶R¡A¶RӧƱæ¡ã ¦]µØ¤]¤£¿ù¡I¦A¬Ý¬ÝÅo¡I ÁÂÁº¦ªù¤H¤j³ø©úµP¡ãÁ°աI¡ã §Ú¶RªºªÑ²¼³£·|©ñ¦n¤@°}¤l¡ã ©Ò¥H©ñµÛµ¥Åo¡I¨C¤äªÑ²¼³£¦³µL¥i¯à¡I @¤ßµ¥¡I¤@©w·|±o¨ì«Ü¤£¿ùªº¦¨ªGªº¡I |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/11 ¤U¤È 03:57:31²Ä 4 ½g¦^À³
|
Ymyu¤j¡A¤£¥Î«È®ð³á ¶¶«K½Æ²ß¤½¥qºô¯¸ªº¤½§i ¥h¦~¦³ÃöJKB-122ªºµ²ªG ´º³Í©óEASL°ê»Ú¨x¯f¤j·|(2020)µoªíNAFLDÁ{§É¸ÕÅç¤G´Áµ²ªG 2020-09-02 EASL_2020 ¤µ¦~«×(2020)°ê»Ú¨x¯f¤j·|©ó8¤ë27¤é¦Ü29¤é¦b^°êÛ´°Á|¿ì¡A¥Ñ©ó¬Ì±¡ªº¼vÅT¡AÁ|¿ì§Î¦¡Âà´«¦¨¬°´Á¤T¤Ñªº½u¤W¨x¯f¤j·|¡A´º³Í¥Í§ÞªºJKB-122¥Î©óªvÀøNAFLDªºÁ{§É¸ÕÅç¤G´Áµ²ªG¡A©ó¦~·|¤W¶i¦æ®ü³øµoªí¡C ¥»¤½¥qJKB-122¤p¤À¤l·sÃĪvÀø«D°sºë©Ê¯×ªÕ¨x¯f¤§²Ä¤G´ÁÁ{§É¸ÕÅç¡AÂǥѫú§ÜToll-Like Receptor 4 (TLR4)¤§§@¥Î¡AªvÀø«D°sºë©Ê¯×ªÕ¨x¯f¡FÀH¾÷¡A¦h¾¯¶q¡AÂùª¼¡A¦w¼¢¾¯±±¨îªºÁ{§É¸ÕÅç¡A¹ê»Ú©Û¦¬¤H¼Æ121¤H¡F¸ÕÅçµ²ªG¦p¤U¡G A.¥»¸ÕÅ窺¥Dn«ü¼Ð (ALT¤U°¶W¹L30%©Î¦^¨ì¥¿±`È¡A¦P®É¨x¯×ªÕ¤U°ªÌ)©ó°ª¾¯¶q²Õ¹F¨ì²Îp¤WÅãµÛ®ÄªG(P=0.04) B.35²@§J²Õ©ó¤Uz¦¸n«ü¼Ð¬Ò¹F¨ì²Îp¤WÅãµÛ®ÄªG¡G a.¾¢¯ó¾L»ÄÂàÓi×Q(AST)¤U°¶W¹L30%©Î¦^´_¨ì¥¿±`ªÌ(P=0.0107¡A¹F¾ã²Õ¤ñ²v70%) b.¤T»Ä¥Ìªo¯×(Triglyceride, TG)¤U° c.®ÖºÏ¦@®¶¥úÃÐ---¯×ªÕ¦Ê¤À¤ñ (MRS--Fat Percentage)¤U°(P=0.0005) d.°ª±K«×Áx©T¾J(High Density Lipoprotein, HDL)¤W¤É(P=0.0084¡A¥»¶µ«ü¼Ð¤É°ª¥Nªí¥¿¦V®ÄªG) C.¦¹¥~¡AJKB-122¥ÎÃĦw¥þ©Ê¬ÒµLºÃ¼{¡C |
|
|
·|û¡Gymyu398810142972 µoªí®É¶¡:2021/3/11 ¤U¤È 02:55:35²Ä 3 ½g¦^À³
|
ÁÂÁº¦ªù¤H¤j¤j¤À¨Éªº¸ê°T¡A§Ú¤]¦b¶R¶i·í¤¤ |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/11 ¤U¤È 02:34:03²Ä 2 ½g¦^À³
|
ÁöµM¬O¥h¦~¤¤ªº·s»D ¦ý¬O¹ï´º³Í·N¸q«D¤Z Àq§J¬O¤°»òµ¥¯Åªº¤½¥q ¬°¤°»ò¿ï¾Ü´º³Í ¦X§@¤§«áªº²Ä¤@Ó¦¨¥\ªº®×¤l ´N¬OTJC0265§Ü¨xÅÖºû¤Æ·sÃÄ ¤]¦¨¥\±ÂÅv¥X¥h ´Á«Ý¤§«áÀ³¸Ó¦³§ó¦hªºÃÄ ¤@°_¦X§@¶}µo¥X¨Ó¡A¤@°_¬Ý¤U¥hÅo ´º³Í¡BÀq§JÄâ¤â¶}µoªvNASHÃĪ« 12:482020/06/19 ¤u°Ó §ù¿·»T/¥x¥_³ø¾É ´º³Í¡]6549¡^19¤é«Å¥¬¡A¸Ó¤½¥q»PMerck Healthcare KGaA¼w°êÀq§J¶°¹Îñqª«½è²¾Âà¦X¬ù¡A¦@¦P¦X§@¶i¦æ¤Æ¦Xª«¦b«D°sºë©Ê¯×ªÕ¨xª¢(NASH)ªvÀø»â°ìÀ³¥Îªº¥i¦æ©Êµû¦ô¡C ¦¹¦¸¦X§@¥Dn¬°Âù¤è°w¹ï²{¦³ªº·sÃĤƦXª«(NCE)¶i¦æ¬ã¨sµû¦ô¡A³z¹L´ú¸Õ¥¥x¨ÓÅçÃÒÂù¤èªº·sÃĦb«D°sºë©Ê¯×ªÕ¨xª¢¤§®ÄªG¡C ¾Ú¤F¸Ñ¡A¦¹¬°°ê¤º¥Í§Þ¤½¥qº¦¸»PMerckÃļt¦X§@¡A±q°Êª«¤À²Õ´ú¸Õ¨ìµ²ªG³ø§iÅçÃÒªº´Á¶¡¬°¥b¦~¡A¦¹¦¸ªº¦X§@¡AÅçÃÒ´º³Í¥Í§Þªø´Á©ó«D°sºë©Ê¯×ªÕ¨xª¢»â°ìªº±M§ð§Þ³N¡A¤wÀò¥@¬É¯ÅÃļtÃöª`¤Î»{¥i¡C¦¹¦¸¦X§@¹ï©ó´º³Í¥Í§Þ·sÃIJ£«~¦b´M¨D°ê»Ú¤j¼t¤Wªº±ÂÅv§ó²K§U¯q¡C ´º³Í¦b·s¤Æ¾Ç¦¨¤À¡]NCE¡^·sÃĪº¶}µo¡A¤w¦³¤£¿ùªº¶i®i¡F¨ä¤¤TWJ-265¡]Autotaxin Inhibitor¡^¦b½Ñ¦hÁ{§É«e¼Ò«¬¤¤Åã¥Ü¥iÆ[Àø®Ä¡A¨ã¦³§Üµoª¢¡B§ÜÅÖºû¤ÆªºÂù«¾÷¨î¡A¥Ø«e¥¿¦b³z¹L»Ú°ê¯ÅCRO¤½¥q¶i¦æ¬ÛÃö©ÊÅçÃÒ¡A¹wp¦b2020¦~²Ä¤T©u¥i§¹¦¨¡AY¦³¤£¿ùªº®ÄªG¤£±Æ°£¥Ó½ÐÁ{§É¸ÕÅç¤Î±Ò°Ê¼Ú¬ü¥«³õ±ÂÅv¡C |
|
|
·|û¡Gº¦ªù¤H10146623 µoªí®É¶¡:2021/3/11 ¤U¤È 02:20:44²Ä 1 ½g¦^À³
|
ÁÂÁ³¯¤j¤§«e¶}ª© ¦]¬°³¯¤j2015¦~¶}ª©¦Ü¤µ ´º³Í¤w¸g«D±`¤£¤@¼Ë ¬G«·s¶}ª©¡A¸ò¦U¦ì¤j¤j¥ý¶i°Q½×🙏 |
|
|
|